KSI vs. VHI, CARE, RHT, ADK, DOC, EKG, ZMD, CNNA, CARE.TO, and UDOC
Should you be buying kneat.com stock or one of its competitors? The main competitors of kneat.com include Vitalhub (VHI), Dialogue Health Technologies (CARE), Reliq Health Technologies (RHT), DIAGNOS (ADK), CloudMD Software & Services (DOC), CardioComm Solutions (EKG), ZoomMed (ZMD), Cann American (CNNA), Dialogue Health Technologies (CARE.TO), and Unidoc Health (UDOC). These companies are all part of the "health information services" industry.
kneat.com vs.
Vitalhub (TSE:VHI) and kneat.com (TSE:KSI) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, community ranking, earnings, risk, institutional ownership, valuation, analyst recommendations, dividends and media sentiment.
In the previous week, kneat.com had 10 more articles in the media than Vitalhub. MarketBeat recorded 11 mentions for kneat.com and 1 mentions for Vitalhub. kneat.com's average media sentiment score of 0.80 beat Vitalhub's score of 0.76 indicating that kneat.com is being referred to more favorably in the news media.
Vitalhub has a net margin of 5.11% compared to kneat.com's net margin of -17.59%. Vitalhub's return on equity of 3.01% beat kneat.com's return on equity.
Vitalhub received 7 more outperform votes than kneat.com when rated by MarketBeat users. However, 100.00% of users gave kneat.com an outperform vote while only 73.33% of users gave Vitalhub an outperform vote.
Vitalhub has a beta of 1.26, meaning that its stock price is 26% more volatile than the S&P 500. Comparatively, kneat.com has a beta of 1.08, meaning that its stock price is 8% more volatile than the S&P 500.
32.4% of Vitalhub shares are held by institutional investors. Comparatively, 13.0% of kneat.com shares are held by institutional investors. 18.6% of Vitalhub shares are held by insiders. Comparatively, 26.0% of kneat.com shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.
Vitalhub has higher revenue and earnings than kneat.com. kneat.com is trading at a lower price-to-earnings ratio than Vitalhub, indicating that it is currently the more affordable of the two stocks.
Vitalhub presently has a consensus target price of C$11.60, suggesting a potential upside of 21.34%. kneat.com has a consensus target price of C$6.00, suggesting a potential downside of 10.98%. Given Vitalhub's higher possible upside, research analysts plainly believe Vitalhub is more favorable than kneat.com.
Summary
Vitalhub beats kneat.com on 12 of the 19 factors compared between the two stocks.
Get kneat.com News Delivered to You Automatically
Sign up to receive the latest news and ratings for KSI and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
kneat.com Competitors List
Related Companies and Tools
This page (TSE:KSI) was last updated on 3/4/2025 by MarketBeat.com Staff
Free KSI Stock Alerts